https://www.prnewswire.com/news-releases/ionis-enters-collaboration-to-advance-next-generation-program-targeting-lpa-for-cardiovascular-disease-301892267.html For those of us with high Lp(a)…looking forward to FDA approval. 🙏❤️🕊 #ionis #pelacarsen #Novartis
RT @SABOURETCardio
#ACC2023 the new frontier is Lp(a) treatment. 2 promising inhibitors, waiting for the Phase 3 #RCT #pelacarsen #olpasiran
#acc2023 #RCT #pelacarsen #olpasiran